Informative Drug Websites Drive Patients To Consult MDs, Survey Finds
This article was originally published in The Pink Sheet Daily
Schering-Plough’s website for Nasonex is cited in a Keynote Systems report as an example of a site driving consumer interest.
You may also be interested in...
Roche will consider requesting a re-examination of the negative decision by the Committee for Medicinal Products for Human Use.
A Phase III trial will compare 40 mg/day glatiramer to the 20 mg/day approved dose.
A National Institute for Health & Clinical Excellence analysis finds cost per quality-adjusted life year gained as high as $83,000.